Valeant Again Boosts Skin Care Biz With $500M PreCision Buy

Law360, New York (February 3, 2014, 1:20 PM EST) -- Valeant Pharmaceutical International Inc., one of the most acquisitive life sciences companies in recent years, said Monday it will pay up to $500 million to fold PreCision Dermatology Inc. into its growing skin care business.

Under the transaction's terms, Quebec-based Valeant will pony up $475 million in cash, plus another $25 million if PreCision hits unspecified sales milestones. The deal adds to a string of pickups aimed at bringing Valeant into the top five drug companies, based on market capitalization, by 2015.

The company has said...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.